Characterization of dengue virus entry into HepG2 cells

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Suksanpaisan, Lukkana ^a,b   Susantad, Tharinee ^a,c   Smith, Duncan R ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Mayo Clinic   (United States)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; SMALL INTERFERING RNA; HYBRID PROTEIN; TRANSFERRIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; COMPETITIVE INHIBITION; CONTROLLED STUDY; DENGUE VIRUS; ENDOCYTOSIS; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VERO CELL; VIRUS CHARACTERIZATION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS STRAIN; ANIMAL; CELL LINE; COATED PIT; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

DENGUE VIRUS; MAMMALIA;

ANIMALS; CELL LINE; CLATHRIN; COATED PITS, CELL-MEMBRANE; DENGUE VIRUS; ENDOCYTOSIS; HUMANS; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; TRANSFERRIN; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 63449089372     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-17     Document Type: Article

References (25)

1. Insider information: what viruses tell us about endocytosis. L Pelkmans A Helenius, Curr Opin Cell Biol 2003 15 414 422 10.1016/S0955-0674(03)00081-4 12892781
2. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. SB Halstead FX Heinz AD Barrett JT Roehrig, Vaccine 2005 23 849 856 10.1016/j.vaccine.2004.03.069 15603884
3. A comparative study of entry modes into C6/36 cells by Semliki Forest and Japanese encephalitis viruses. T Hase PL Summers WH Cohen, Arch Virol 1989 108 101 114 10.1007/BF01313747 2596972
4. Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. T Hase PL Summers KH Eckels, Arch Virol 1989 104 129 143 10.1007/BF01313814 2564270
5. A different mode of entry by dengue-2 neutralisation escape mutant virus. HY Lim ML Ng, Arch Virol 1999 144 989 995 10.1007/s007050050561 10416380
6. Alteration of virus entry mode: a neutralisation mechanism for Dengue-2 virus. SY Se-Thoe AE Ling MM Ng, J Med Virol 2000 62 364 376 10.1002/1096-9071(200011)62:3<364::AID-JMV9>3.0.CO;2-S 11055247
7. Rab 5 is required for the cellular entry of dengue and West Nile viruses. MN Krishnan B Sukumaran U Pal H Agaisse JL Murray TW Hodge E Fikrig, J Virol 2007 81 4881 4885 17301152 10.1128/JVI.02210-06
8. Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells. JJ Chu PW Leong ML Ng, Virology 2006 349 463 475 10.1016/j.virol.2006.01. 022 16490225
9. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. JJ Chu ML Ng, J Virol 2004 78 10543 10555 15367621 10.1128/JVI.78.19.10543-10555.2004
10. Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. M Nawa T Takasaki K Yamada I Kurane T Akatsuka, J Gen Virol 2003 84 1737 1741 10.1099/vir.0.18883-0 12810867
11. Behavior of the dengue virus in solution. P Sithisarn L Suksanpaisan C Thepparit DR Smith, J Med Virol 2003 71 532 539 10.1002/jmv.10520 14556266
12. Internalization and propagation of the dengue virus in human hepatoma (HepG2) cells. C Thepparit W Phoolcharoen L Suksanpaisan DR Smith, Intervirology 2004 47 78 86 10.1159/000077830 15192271
13. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. C Thepparit DR Smith, J Virol 2004 78 12647 12656 15507651 10.1128/JVI.78.22.12647-12656.2004
14. Analysis of the steps involved in Dengue virus entry into host cells. SL Hung PL Lee HW Chen LK Chen CL Kao CC King, Virology 1999 257 156 167 10.1006/viro.1999.9633 10208929
15. Adaptation of the plaque assay methodology for dengue virus infected HepG2 cells. P Chingsuwanrote L Suksanpaisan DR Smith, J Virol Methods 2004 116 119 121 10.1016/j.jviromet.2003.11.002 14738977
16. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. EA Henchal MK Gentry JM McCown WE Brandt, Am J Trop Med Hyg 1982 31 830 836 6285749
17. Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70. A Cabrera-Hernandez C Thepparit L Suksanpaisan DR Smith, J Med Virol 2007 79 386 392 10.1002/jmv.20786 17311328
18. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. S Jindadamrongwech C Thepparit DR Smith, Arch Virol 2004 149 915 927 10.1007/s00705-003-0263-x 15098107
19. Internalization of the dengue virus is cell cycle modulated in HepG2, but not Vero cells. W Phoolcharoen DR Smith, J Med Virol 2004 74 434 441 10.1002/jmv.20195 15368519
20. Infection of human primary hepatocytes with dengue virus serotype 2. L Suksanpaisan A Cabrera-Hernandez DR Smith, J Med Virol 2007 79 300 307 10.1002/jmv.20798 17245728
21. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. A Benmerah M Bayrou N Cerf-Bensussan A Dautry-Varsat, J Cell Sci 1999 112 Pt 9 1303 1311 10194409
22. AP-2/Eps15 interaction is required for receptor-mediated endocytosis. A Benmerah C Lamaze B Begue SL Schmid A Dautry-Varsat N Cerf-Bensussan, J Cell Biol 1998 140 1055 1062 9490719 10.1083/jcb.140.5.1055
23. eps15 and eps15R are essential components of the endocytic pathway. R Carbone S Fre G Iannolo F Belleudi P Mancini PG Pelicci MR Torrisi PP Di Fiore, Cancer Res 1997 57 5498 5504 9407958
24. Endocytosis without clathrin coats. BJ Nichols J Lippincott-Schwartz, Trends Cell Biol 2001 11 406 412 10.1016/S0962-8924(01)02107-9 11567873
25. Clathrin. T Kirchhausen, Annu Rev Biochem 2000 69 699 727 10.1146/annurev.biochem.69.1.699 10966473